317 related articles for article (PubMed ID: 32086979)
1. MicroRNA-361-3p is a potent therapeutic target for oral squamous cell carcinoma.
Ogawa H; Nakashiro KI; Tokuzen N; Kuribayashi N; Goda H; Uchida D
Cancer Sci; 2020 May; 111(5):1645-1651. PubMed ID: 32086979
[TBL] [Abstract][Full Text] [Related]
2. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
Wang X; Li H; Shi J
Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
[TBL] [Abstract][Full Text] [Related]
3. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1.
Chou ST; Peng HY; Mo KC; Hsu YM; Wu GH; Hsiao JR; Lin SF; Wang HD; Shiah SG
J Exp Clin Cancer Res; 2019 Jun; 38(1):281. PubMed ID: 31253192
[TBL] [Abstract][Full Text] [Related]
5. MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.
Guo J; Wen N; Yang S; Guan X; Cang S
Biomed Pharmacother; 2018 Aug; 104():77-86. PubMed ID: 29772443
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of miR-103a-3p suppresses the proliferation in oral squamous cell carcinoma cells via targeting RCAN1.
Zhang G; Chen Z; Zhang Y; Li T; Bao Y; Zhang S
Neoplasma; 2020 May; 67(3):461-472. PubMed ID: 32122140
[TBL] [Abstract][Full Text] [Related]
7. Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
Tseng HH; Tseng YK; You JJ; Kang BH; Wang TH; Yang CM; Chen HC; Liou HH; Liu PF; Ger LP; Tsai KW
Anticancer Res; 2017 Mar; 37(3):1059-1066. PubMed ID: 28314265
[TBL] [Abstract][Full Text] [Related]
8. MiR-223-3p inhibits proliferation and metastasis of oral squamous cell carcinoma by targeting SHOX2.
Sun C; Liu XH; Sun YR
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6927-6934. PubMed ID: 31486492
[TBL] [Abstract][Full Text] [Related]
9. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.
He L; Ping F; Fan Z; Zhang C; Deng M; Cheng B; Xia J
Biomed Pharmacother; 2020 Jan; 121():109553. PubMed ID: 31704611
[TBL] [Abstract][Full Text] [Related]
10. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
Cai J; Qiao B; Gao N; Lin N; He W
Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
[TBL] [Abstract][Full Text] [Related]
11. miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2.
Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R
Pathol Res Pract; 2019 Apr; 215(4):660-667. PubMed ID: 30606659
[TBL] [Abstract][Full Text] [Related]
12. miRNA-99b-3p functions as a potential tumor suppressor by targeting glycogen synthase kinase-3β in oral squamous cell carcinoma Tca-8113 cells.
He K; Tong D; Zhang S; Cai D; Wang L; Yang Y; Gao L; Chang S; Guo B; Song T; Li A; Huang C
Int J Oncol; 2015 Oct; 47(4):1528-36. PubMed ID: 26315788
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-16 functions as a tumor-suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2.
Wang X; Li GH
J Cell Physiol; 2018 Dec; 233(12):9447-9457. PubMed ID: 30136280
[TBL] [Abstract][Full Text] [Related]
14. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway.
Huang WC; Jang TH; Tung SL; Yen TC; Chan SH; Wang LH
J Exp Clin Cancer Res; 2019 Feb; 38(1):89. PubMed ID: 30782177
[TBL] [Abstract][Full Text] [Related]
15. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC
Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029
[TBL] [Abstract][Full Text] [Related]
16. MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.
Wang K; Jin J; Ma T; Zhai H
J Cell Mol Med; 2017 Dec; 21(12):3730-3740. PubMed ID: 28780773
[TBL] [Abstract][Full Text] [Related]
17. circ-PKD2 inhibits carcinogenesis via the miR-204-3p/APC2 axis in oral squamous cell carcinoma.
Gao L; Zhao C; Li S; Dou Z; Wang Q; Liu J; Ren W; Zhi K
Mol Carcinog; 2019 Oct; 58(10):1783-1794. PubMed ID: 31206208
[TBL] [Abstract][Full Text] [Related]
18. Intronic miR-6741-3p targets the oncogene SRSF3: Implications for oral squamous cell carcinoma pathogenesis.
More DA; Singh N; Mishra R; Muralidharan HP; Gopinath KS; Gopal C; Kumar A
PLoS One; 2024; 19(5):e0296565. PubMed ID: 38781195
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.
Li M; Ning J; Li Z; Fei Q; Zhao C; Ge Y; Wang L
Biomed Pharmacother; 2019 Oct; 118():109259. PubMed ID: 31369989
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
Li L; Ma HQ
Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
